Aggressive systemic mastocytosis complicated by protein-losing enteropathy

Dig Liver Dis. 2007 Jul;39(7):693-7. doi: 10.1016/j.dld.2006.06.003. Epub 2006 Jul 14.

Abstract

A 46-year-old woman was admitted to the hospital with complaints of chronic diarrhoea, vomiting and severe muscle weakness. Clinical examination showed a lethargic, malnourished, dehydrated patient with ascites and bilateral leg oedema. Laboratory evaluation revealed mild normochromic normocytic anaemia and severe hypoproteinaemia with hypoalbuminaemia. Upper gastrointestinal endoscopy showed a thickened, friable duodenal mucosa with multiple erosions. Colonoscopy revealed nodular, pseudopolypoid lesions with patchy erosions in the left hemicolon. Haematoxylin-eosin stained sections from biopsies of endoscopically abnormal bowel segments showed multi-focal aggregates of large, histiocyte-like cells with abundant pale cytoplasm in the lamina propria. These cells were negative on PAS, Ziehl-Neelsen, Giemsa and toluidine blue stains. Their immunophenotype was CD68 (+), c-kit/CD117 (+) and mast cell tryptase (+), which is consistent with mast cells. A trephine biopsy showed diffuse replacement of the bone marrow by atypical, monomorphic, frequently spindle-shaped mast cells. No associated haematopoietic malignancy was detected. The final diagnosis was aggressive systemic mastocytosis with involvement of the gastrointestinal tract complicated by protein-losing enteropathy. This association has not been reported previously. The patient has been treated with prednisolone and interferon-alpha and has since recovered.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Colonoscopy
  • Female
  • Humans
  • Immunologic Factors / therapeutic use
  • Interferon-alpha
  • Mastocytosis, Systemic / complications*
  • Mastocytosis, Systemic / diagnosis*
  • Mastocytosis, Systemic / drug therapy
  • Mastocytosis, Systemic / pathology
  • Middle Aged
  • Prednisolone / therapeutic use
  • Protein-Losing Enteropathies / complications*
  • Protein-Losing Enteropathies / diagnosis*
  • Protein-Losing Enteropathies / drug therapy
  • Protein-Losing Enteropathies / pathology

Substances

  • Anti-Inflammatory Agents
  • Immunologic Factors
  • Interferon-alpha
  • Prednisolone